Literature DB >> 20038197

STAT-phosphorylation-independent induction of interferon regulatory factor-9 by interferon-beta.

M R Sandhya Rani1, Ed Croze, Tao Wei, Jennifer Shrock, Anupama Josyula, Dhananjaya V Kalvakolanu, Richard M Ransohoff.   

Abstract

Type I interferon (IFN)-dependent STAT1 and STAT2 activation requires specific tyrosine residues (337Y and 512Y) located in the cytoplasmic domain of IFNAR-2c, the beta-subunit of the human type I IFN receptor. To identify STAT activation-independent induction of ISGs, we used a mutant cell line in which both 337Y and 512Y were substituted with phenylalanine (337F512F or FF mutant). In these cells, type I IFN failed to activate STAT1, STAT2, and STAT3 did not induce well-characterized ISGs and did not exert antiviral or antiproliferative effects. Using Oligonucleotide array (Affymetrix) analysis, we showed that interferon regulatory factor-9 (IRF-9) was the only gene induced by IFN-beta in FF cells. Transient transfection analysis using an IRF-9 promoter-reporter luciferase construct in FF cells confirmed induction of the IRF-9 transcription unit by IFN-beta. EMSA analysis using an IFN-stimulated response element (ISRE)-like sequence on the IRF-9 promoter detected 2 novel DNA-binding complexes induced in nuclear extracts of IFN-beta-treated FF cells. Supershift experiments identified the proteins IRF-1 and C/EBP-beta in the complex. These studies provide the first evidence that signaling pathways leading to gene transcription are activated by IFN-beta independent of STAT phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20038197      PMCID: PMC3096491          DOI: 10.1089/jir.2009.0032

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  38 in total

Review 1.  Complex roles of Stat1 in regulating gene expression.

Authors:  C V Ramana; M Chatterjee-Kishore; H Nguyen; G R Stark
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 2.  Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

Authors:  John J O'Shea; Massimo Gadina; Robert D Schreiber
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 3.  A road map for those who don't know JAK-STAT.

Authors:  David S Aaronson; Curt M Horvath
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

4.  Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons.

Authors:  Andreas Pilz; Katrin Ramsauer; Hamid Heidari; Michael Leitges; Pavel Kovarik; Thomas Decker
Journal:  EMBO Rep       Date:  2003-03-21       Impact factor: 8.807

5.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

6.  Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells.

Authors:  T Charis Wagner; Sharlene Velichko; David Vogel; M R Sandhya Rani; Stewart Leung; Richard M Ransohoff; George R Stark; H Daniel Perez; Ed Croze
Journal:  J Biol Chem       Date:  2001-10-26       Impact factor: 5.157

7.  CCAAT/enhancer-binding protein beta mediates interferon-gamma-induced p48 (ISGF3-gamma ) gene transcription in human monocytic cells.

Authors:  W Xiao; L Wang; X Yang; T Chen; D Hodge; P F Johnson; W Farrar
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

8.  A role for NF-kappa B in the induction of beta-R1 by interferon-beta.

Authors:  M R Rani; A R Asthagiri; A Singh; N Sizemore; S S Sathe; X Li; J D DiDonato; G R Stark; R M Ransohoff
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

9.  MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma.

Authors:  Sanjit K Roy; Junbo Hu; Qingjun Meng; Ying Xia; Paul S Shapiro; Sekhar P M Reddy; Leonidas C Platanias; Daniel J Lindner; Peter F Johnson; Catrin Pritchard; Gilles Pagés; Jacques Pouyssegur; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

10.  Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene.

Authors:  M R Sandhya Rani; Linda Hibbert; Nywana Sizemore; George R Stark; Richard M Ransohoff
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

View more
  5 in total

1.  Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production.

Authors:  Xiaofei Gao; Thanh H Pham; Leigh Ann Feuerbacher; Kangming Chen; Michael P Hays; Gyanendra Singh; Christian Rueter; Ramon Hurtado-Guerrero; Philip R Hardwidge
Journal:  J Biol Chem       Date:  2016-07-07       Impact factor: 5.157

2.  Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.

Authors:  Xaioyan Xuan; Shanshan Li; Xi Lou; Xianzhao Zheng; Yunyun Li; Feng Wang; Yuan Gao; Hongyan Zhang; Hongliu He; Qingru Zeng
Journal:  Mol Biol Rep       Date:  2014-11-19       Impact factor: 2.316

3.  Two Interferon-Stimulated Response Elements Cooperatively Regulate Interferon-Stimulated Gene Expression in West Nile Virus-Infected IFNAR-/- Mouse Embryo Fibroblasts.

Authors:  Dan Cui; Emilio E Espínola; Komal Arora; Margo A Brinton
Journal:  J Virol       Date:  2021-09-08       Impact factor: 5.103

4.  STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes.

Authors:  Elin Edsbäcker; Jason T Serviss; Iryna Kolosenko; Caroline Palm-Apergi; Angelo De Milito; Katja Pokrovskaja Tamm
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 5.  The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.

Authors:  Gideon Schreiber
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.